Winfield Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $215K | Sell |
3,620
-40
| -1% | -$2.38K | 0.08% | 147 |
|
|
2021
Q4 | $266K | Buy |
3,660
+565
| +18% | +$41.1K | 0.09% | 137 |
|
|
2021
Q3 | $216K | Buy |
+3,095
| New | +$216K | 0.08% | 142 |
|
|
2018
Q1 | – | Sell |
-305
| Closed | -$23K | – | 322 |
|
|
2017
Q4 | $23K | Sell |
305
-15
| -5% | -$1.13K | 0.01% | 285 |
|
|
2017
Q3 | $26K | Sell |
320
-29
| -8% | -$2.36K | 0.01% | 257 |
|
|
2017
Q2 | $24K | Buy |
349
+229
| +191% | +$15.7K | 0.01% | 263 |
|
|
2017
Q1 | $8K | Sell |
120
-960
| -89% | -$64K | ﹤0.01% | 411 |
|
|
2016
Q4 | $77K | Sell |
1,080
-2,355
| -69% | -$168K | 0.05% | 155 |
|
|
2016
Q3 | $272K | Sell |
3,435
-5,369
| -61% | -$425K | 0.17% | 99 |
|
|
2016
Q2 | $734K | Sell |
8,804
-170
| -2% | -$14.2K | 0.48% | 56 |
|
|
2016
Q1 | $824K | Sell |
8,974
-536
| -6% | -$49.2K | 0.56% | 47 |
|
|
2015
Q4 | $962K | Sell |
9,510
-1,525
| -14% | -$154K | 0.64% | 41 |
|
|
2015
Q3 | $1.08M | Sell |
11,035
-950
| -8% | -$93.3K | 0.81% | 38 |
|
|
2015
Q2 | $1.4M | Hold |
11,985
| – | – | 0.96% | 31 |
|
|
2015
Q1 | $1.18M | Sell |
11,985
-1,545
| -11% | -$152K | 0.82% | 36 |
|
|
2014
Q4 | $1.28M | Sell |
13,530
-2,730
| -17% | -$257K | 0.94% | 29 |
|
|
2014
Q3 | $1.73M | Buy |
16,260
+1,675
| +11% | +$178K | 1.29% | 16 |
|
|
2014
Q2 | $1.21M | Buy |
14,585
+1,550
| +12% | +$128K | 0.88% | 34 |
|
|
2014
Q1 | $924K | Buy |
+13,035
| New | +$924K | 0.76% | 43 |
|